Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Healthcare Industry News Sai Life Sciences (NSE: SAILIFE) accelerates talent expansion to support complex drug development demand Sai Life Sciences Limited plans 700+ hires in FY27 as it scales R&D and manufacturing. Find out what this expansion signals for India’s CRDMO sector. bySrinathFebruary 22, 2026